CVS Health Corp
CVS79.080USD
+1.040+1.33%
Cierre 12/24, 13:00（ET）Cotizaciones retrasadas 15 min
100.43BCap. mercado
210.43P/E TTM
Más Datos de CVS Health Corp Compañía
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
Información de CVS Health Corp
Símbolo de cotizaciónCVS
Nombre de la empresaCVS Health Corp
Fecha de salida a bolsaNov 06, 2088
Director ejecutivoJoyner (J. David David)
Número de empleados300000
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 06
DirecciónOne Cvs Dr.
CiudadWOONSOCKET
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02895
Teléfono14017651500
Sitio Webhttps://cvshealth.com/
Símbolo de cotizaciónCVS
Fecha de salida a bolsaNov 06, 2088
Director ejecutivoJoyner (J. David David)
Ejecutivos de CVS Health Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-13.94%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+13.76%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+38.63%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
5.93K
+38.63%
Mr. Roger N. Farah
Mr. Roger N. Farah
Director
Director
4.12K
-92.40%
Ms. Alecia A. Decoudreaux, J.D.
Ms. Alecia A. Decoudreaux, J.D.
Independent Director
Independent Director
2.97K
--
Dr. Amy L. Compton-Phillips, M.D.
Dr. Amy L. Compton-Phillips, M.D.
Executive Vice President and Chief Medical Officer
Executive Vice President and Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
40.60K
-13.94%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
13.66K
+13.76%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
5.93K
+38.63%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy
55.35B
55.96%
Premiums
34.20B
34.57%
Front Store
5.37B
5.43%
Other
3.52B
3.55%
Net investment income(loss)
487.00M
0.49%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Pharmacy
55.35B
55.96%
Premiums
34.20B
34.57%
Front Store
5.37B
5.43%
Other
3.52B
3.55%
Net investment income(loss)
487.00M
0.49%
Estadísticas de accionistas
Actualizado: sáb., 15 de nov
Actualizado: sáb., 15 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.76%
Capital World Investors
5.39%
BlackRock Institutional Trust Company, N.A.
5.07%
State Street Investment Management (US)
4.64%
Otro
69.82%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.31%
Dodge & Cox
5.76%
Capital World Investors
5.39%
BlackRock Institutional Trust Company, N.A.
5.07%
State Street Investment Management (US)
4.64%
Otro
69.82%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
46.52%
Investment Advisor/Hedge Fund
31.44%
Hedge Fund
3.09%
Research Firm
2.77%
Pension Fund
2.16%
Bank and Trust
1.96%
Sovereign Wealth Fund
1.65%
Individual Investor
1.06%
Insurance Company
0.10%
Otro
9.25%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
3559
1.14B
91.37%
+184.05K
2025Q3
3681
1.14B
91.69%
+21.03M
2025Q2
3720
1.12B
91.24%
+11.94M
2025Q1
3762
1.11B
87.65%
+493.45K
2024Q4
3844
1.07B
85.40%
+28.70M
2024Q3
3797
1.04B
85.89%
-7.86M
2024Q2
3821
1.05B
84.06%
+19.75M
2024Q1
3841
1.03B
84.50%
-33.86M
2023Q4
3855
1.05B
81.50%
+16.24M
2023Q3
3736
1.03B
81.41%
+4.51M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
119.78M
9.44%
+2.04M
+1.74%
Jun 30, 2025
Dodge & Cox
73.29M
5.78%
-170.36K
-0.23%
Jun 30, 2025
Capital World Investors
66.96M
5.28%
-1.44M
-2.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
63.56M
5.01%
-1.40M
-2.15%
Jun 30, 2025
State Street Investment Management (US)
58.79M
4.64%
+800.41K
+1.38%
Jun 30, 2025
Fidelity Management & Research Company LLC
37.59M
2.96%
+13.37M
+55.22%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.64M
2.26%
+675.82K
+2.42%
Jun 30, 2025
Capital International Investors
26.39M
2.08%
+202.05K
+0.77%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
19.70M
1.55%
+994.06K
+5.31%
Jun 30, 2025
BlackRock Investment Management, LLC
16.04M
1.26%
+10.29M
+178.77%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Healthcare Providers ETF
12.05%
Invesco S&P Ultra Dividend Revenue ETF
6.26%
Coastal Compass 100 ETF
5.67%
Davis Select US Equity ETF
5.6%
Simplify Health Care ETF
5.48%
VanEck Retail ETF
4.53%
iShares US Consumer Staples ETF
4.18%
Invesco S&P 500 Pure Value ETF
3.71%
Invesco S&P 500 Enhanced Value ETF
3.03%
JPMorgan Healthcare Leaders ETF
2.99%
Ver más
iShares U.S. Healthcare Providers ETF
Proporción12.05%
Invesco S&P Ultra Dividend Revenue ETF
Proporción6.26%
Coastal Compass 100 ETF
Proporción5.67%
Davis Select US Equity ETF
Proporción5.6%
Simplify Health Care ETF
Proporción5.48%
VanEck Retail ETF
Proporción4.53%
iShares US Consumer Staples ETF
Proporción4.18%
Invesco S&P 500 Pure Value ETF
Proporción3.71%
Invesco S&P 500 Enhanced Value ETF
Proporción3.03%
JPMorgan Healthcare Leaders ETF
Proporción2.99%
Dividendos
Un total de
14.66B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sep 17, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 03, 2025 going ex on Oct 23, 2025
Oct 23, 2025
Nov 03, 2025
Oct 23, 2025
Jul 07, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2025 going ex on Jul 22, 2025
Jul 22, 2025
Aug 01, 2025
Jul 22, 2025
Mar 20, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2025 going ex on Apr 22, 2025
Apr 22, 2025
May 01, 2025
Apr 22, 2025
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
Jul 07, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 01, 2023
Jul 20, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de CVS Health Corp?
Los cinco principales accionistas de CVS Health Corp son:
The Vanguard Group, Inc. posee 119.78M acciones, lo que representa el 9.44% del total de acciones.
Dodge & Cox posee 73.29M acciones, lo que representa el 5.78% del total de acciones.
Capital World Investors posee 66.96M acciones, lo que representa el 5.28% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 63.56M acciones, lo que representa el 5.01% del total de acciones.
State Street Investment Management (US) posee 58.79M acciones, lo que representa el 4.64% del total de acciones.
The Vanguard Group, Inc. posee 119.78M acciones, lo que representa el 9.44% del total de acciones.
Dodge & Cox posee 73.29M acciones, lo que representa el 5.78% del total de acciones.
Capital World Investors posee 66.96M acciones, lo que representa el 5.28% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 63.56M acciones, lo que representa el 5.01% del total de acciones.
State Street Investment Management (US) posee 58.79M acciones, lo que representa el 4.64% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de CVS Health Corp?
Los tres principales tipos de accionista de CVS Health Corp son:
The Vanguard Group, Inc.
Dodge & Cox
Capital World Investors
The Vanguard Group, Inc.
Dodge & Cox
Capital World Investors
¿Cuántas instituciones poseen acciones de CVS Health Corp (CVS)?
A fecha de 2025Q4, 3559 instituciones poseen acciones de CVS Health Corp, con un valor de mercado combinado de aproximadamente 1.14B, lo que representa el 91.37% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.32%.
¿Cuál es la mayor fuente de ganancias de CVS Health Corp?
El FY2025Q2, el segmento empresarial Pharmacy generó la ganancia más alta para CVS Health Corp, ascendiendo a 55.35B y representando el 55.96% de la ganancia total.
